Target Serum Sodium and Osmolality for 3% Saline Post-Stroke

Primary Targets

The American College of Surgeons and American Society of Anesthesiologists recommend a target serum sodium concentration of 145-155 mmol/L for continuous 3% saline infusion in stroke patients with elevated intracranial pressure 1, 2

The American Heart Association recommends avoiding sodium levels >155-160 mmol/L to prevent complications including osmotic demyelination syndrome 1
Osmolality should remain <296 mOsm/kg during the initial 7 days when possible, as elevated osmolality (>296 mOsm/kg) has been associated with increased 3-month mortality in acute stroke patients 3, 4

Measure serum sodium within 6 hours of any bolus administration to guide further therapy, as recommended by the American College of Surgeons and American Society of Anesthesiologists 1, 2

The maximum ICP-lowering effect of 3% saline occurs 10-15 minutes after administration and lasts 2-4 hours, according to the American College of Surgeons and American Society of Anesthesiologists 1, 2

The AHA/ASA guidelines emphasize that both hypovolemia and hypervolemia are harmful in acute ischemic stroke, making careful fluid balance essential, with a goal of euvolemia 3, 4
Despite effectiveness in reducing ICP (Grade A evidence), hypertonic saline has not been shown to improve neurological outcomes (Grade B) or survival (Grade A) in randomized controlled trials, according to the American College of Surgeons and American Society of Anesthesiologists 1, 2
The American Heart Association recommends avoiding hypotonic solutions, such as 5% dextrose or 0.45% saline, as these distribute into intracellular spaces and may worsen cerebral edema 3, 4